Drugs / AGE Serum
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT07558603 Comparator | Apr → Aug 2026 overdue | cutis laxa | Goldman, Butterwick, Fitzpatrick and Groff | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGE Serum | “AGE Serum is a topical that contains a high concentration of 30% Proxylane and a synergistic blend of fruit-derived flavonoids (blueberry, pomegranate) and Cassia alata extract.” NCT07558603 ↗ |
| Route | Topical | “apply a topical serum” NCT07558603 ↗ |